The UAE regulates pharmaceuticals through the Ministry of Health and Prevention, commonly abbreviated MoHAP, working alongside emirate-level health authorities such as the Dubai Health Authority and the Department of Health in Abu Dhabi. Medicines are classified into categories that determine how they can legally be obtained, ranging from over-the-counter products to tightly controlled prescription-only substances.
Hormonal pharmaceuticals with significant physiological effects, including hCG, fall into the prescription-only category. This classification reflects both the medical seriousness of these substances and the potential for harm if used without proper diagnosis and monitoring.
Prescription-only status means hCG cannot legally be sold over the counter, imported for personal use without authorization, or obtained through informal or online channels operating outside the licensed UAE pharmaceutical system. Legal access requires a physician evaluation and a valid prescription, dispensed through a licensed pharmacy.
This framework applies uniformly regardless of the intended use, whether that is fertility treatment discussed in our article on hCG and male fertility, IVF cycles covered in our article on hCG in fertility treatment, or any other indication.
Pharmacies dispensing hCG are themselves subject to licensing requirements around storage, record-keeping, and verification of a valid prescription before dispensing, which closes the loop between a physician's decision to prescribe and the patient actually receiving the medication through a controlled channel.
Bringing prescription pharmaceuticals into the UAE without proper documentation, or ordering them from international sellers who are not licensed to dispense into the UAE market, generally falls outside what is legally permitted, and enforcement of pharmaceutical import rules is a serious matter under UAE law.
This is a separate but related concern to the quality and sourcing risks discussed in our article on recombinant versus urinary hCG manufacturing, since products obtained outside licensed channels also cannot be verified for authenticity or purity.
Prescription control for a hormone like hCG exists because inappropriate or unsupervised use carries real health risks, and because verifying the legitimate clinical need for the substance requires professional medical judgment that a retail or online transaction cannot provide.
This is the same underlying reasoning that applies across most modern healthcare systems internationally, not a UAE-specific restriction, though enforcement and licensing specifics are governed locally by MoHAP and emirate health authorities.
REVIVE LAB UAE operates entirely within the non-prescription research peptide category, supplying products intended for laboratory and research use rather than pharmaceutical treatment. HCG, as a prescription-only pharmaceutical, falls outside that category entirely, and REVIVE LAB UAE does not sell, stock, or supply it in any form.